GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nanollose NC6.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.07

—

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2026

Revenue

—

FY2017FY2026

Net income

−A$2.4m

FY2017FY2026

Free cash flow

−A$1.8m

FY2017FY2026

Shareholders' equity

A$1.2m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue—A$11,950A$12,501A$412,164A$224,611A$322,859A$461,847A$235,846A$117,167A$1,500
Research and developmentA$817,828A$286,520A$361,453A$353,875A$448,164A$393,433A$474,557A$725,411A$610,613A$299,418
Operating income−A$2.7m−A$1.6m−A$1.2m−A$1.3m−A$1.7m−A$905,606−A$1.6m−A$2.5m−A$2.2m−A$1.1m
Net income−A$2.4m−A$1.4m−A$1.2m−A$1.3m−A$1.6m−A$931,045−A$1.2m−A$2.0m−A$1.7m−A$820,346
Diluted earnings per share-0.01-0.00-0.01-0.01-0.01-0.01-0.01-0.02-0.02-0.01

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsA$1.4mA$747,788A$241,951A$633,238A$1.9mA$3.4mA$1.0mA$1.3mA$3.2mA$151,352
Cash and short-term investmentsA$1.3mA$617,318A$138,755A$548,248A$1.6mA$3.0mA$839,161A$1.1mA$3.0mA$40,211
Total liabilitiesA$225,403A$351,377A$465,643A$181,606A$181,509A$507,834A$236,752A$158,218A$160,375A$188,650
DebtA$7,172A$13,086A$42,530A$11,519A$38,093A$37,880A$58,129A$58,124—A$60,973
Shareholders' equityA$1.2mA$396,411−A$223,692A$451,632A$1.7mA$2.9mA$785,218A$1.1mA$3.0m−A$37,298
Shares outstanding401m305m173m162m148m149m110m83m75m60m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−A$1.8m−A$1.1m−A$900,953−A$1.0m−A$1.4m−A$935,186−A$945,594−A$1.9m−A$1.6m−A$574,014
Capital spending−A$4—−A$3—−A$5,352−A$72,153−A$1,091−A$37,209−A$80,196−A$4,989
Free cash flow−A$1.8m−A$1.1m−A$900,956−A$1.0m−A$1.4m−A$1.0m−A$946,685−A$1.9m−A$1.7m−A$579,003
Dividends paid—————−A$3.2m−A$33,825−A$38,668−A$4.2m—

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Mar 2023
Revenue—A$990A$6,040A$5,007A$11,626A$292,413A$412,164A$206,082
Operating income−A$1.2m−A$1.5m−A$920,902−A$694,418−A$631,911−A$617,914−A$389,175−A$170,158
Net income−A$867,953−A$1.5m−A$700,771−A$725,681−A$639,649−A$516,904−A$365,781−A$182,890
Diluted earnings per share-0.00-0.01-0.00-0.00-0.00-0.00-0.00-0.00
Cash from operations—−A$1.0m——————
Total assetsA$1.4mA$434,759A$747,788A$569,295A$241,951A$923,042A$633,238A$633,238
Cash and short-term investmentsA$1.3mA$274,973A$617,318A$405,008A$138,755A$705,205A$548,248A$548,248
DebtA$7,172A$250,205A$13,086A$291,313A$42,530A$400,472A$11,519—
Shareholders' equityA$1.2m−A$169,751A$396,411−A$573,932−A$223,692A$154,122A$451,632−A$671,763

Growth per year

Compound annual rate

3 years5 years10 years
Operating income28.5%24.4%97.0%
Net income21.2%20.8%73.1%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-11.4-10.5-2.8-1.7-3.1-10.1-3.0-1.2-2.2-7.8
Price to sales——262.65.521.429.28.210.132.2—

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.